DE69829567D1 - Angiotensinderivate - Google Patents

Angiotensinderivate

Info

Publication number
DE69829567D1
DE69829567D1 DE69829567T DE69829567T DE69829567D1 DE 69829567 D1 DE69829567 D1 DE 69829567D1 DE 69829567 T DE69829567 T DE 69829567T DE 69829567 T DE69829567 T DE 69829567T DE 69829567 D1 DE69829567 D1 DE 69829567D1
Authority
DE
Germany
Prior art keywords
angiotensin
derivatives
angiotensin derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69829567T
Other languages
English (en)
Other versions
DE69829567T2 (de
Inventor
James Francis Glover
Arthur Rushton
Phillip John Morgan
Stephen Clinton Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Protherics Medicines Development Ltd
Original Assignee
Proteus Molecular Design Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9713361.5A external-priority patent/GB9713361D0/en
Priority claimed from GB9808696A external-priority patent/GB9808696D0/en
Application filed by Proteus Molecular Design Ltd filed Critical Proteus Molecular Design Ltd
Application granted granted Critical
Publication of DE69829567D1 publication Critical patent/DE69829567D1/de
Publication of DE69829567T2 publication Critical patent/DE69829567T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/14—Angiotensins: Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
DE69829567T 1997-06-24 1998-06-23 Angiotensinderivate Expired - Lifetime DE69829567T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9713361 1997-06-24
GBGB9713361.5A GB9713361D0 (en) 1997-06-24 1997-06-24 Peptide derivatives
GB9808696 1998-04-23
GB9808696A GB9808696D0 (en) 1998-04-23 1998-04-23 Peptide derivatives
PCT/GB1998/001833 WO1998058952A1 (en) 1997-06-24 1998-06-23 Angiotensin derivatives

Publications (2)

Publication Number Publication Date
DE69829567D1 true DE69829567D1 (de) 2005-05-04
DE69829567T2 DE69829567T2 (de) 2006-02-16

Family

ID=26311786

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69829567T Expired - Lifetime DE69829567T2 (de) 1997-06-24 1998-06-23 Angiotensinderivate

Country Status (13)

Country Link
US (1) US20090105150A1 (de)
EP (2) EP1001978B1 (de)
JP (1) JP4850321B2 (de)
AR (1) AR014884A1 (de)
AT (1) ATE292143T1 (de)
AU (1) AU748903B2 (de)
CA (1) CA2294996C (de)
DE (1) DE69829567T2 (de)
DK (1) DK1001978T3 (de)
ES (1) ES2241147T3 (de)
NZ (1) NZ501832A (de)
PT (1) PT1001978E (de)
WO (1) WO1998058952A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000071751A1 (en) * 1999-05-21 2000-11-30 Myriad Genetics, Inc. Diabetes gene
US6902888B1 (en) 1999-05-21 2005-06-07 Myriad Genetics, Inc. Diabetes gene
MXPA04002644A (es) 2001-10-05 2004-07-08 Cytos Biotechnology Ag Conjugados que portan un peptido de angiotensina y usos de los mismos.
US7115266B2 (en) * 2001-10-05 2006-10-03 Cytos Biotechnology Ag Angiotensin peptide-carrier conjugates and uses thereof
EP1432443B1 (de) * 2001-10-05 2009-01-21 Cytos Biotechnology AG Angiotensin-träger konjugate und deren verwendung
EP2455388A1 (de) 2010-11-23 2012-05-23 LanthioPep B.V. Neuartige Rezeptoragonisten von Angiotensin des Typs 2 (AT2) und Verwendungen dafür
CN114957400B (zh) * 2022-06-10 2024-02-23 郑州伊美诺生物技术有限公司 人工修饰的血管紧张素ii及血管紧张素ⅱ酶标记物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4384995A (en) * 1980-01-16 1983-05-24 The Ohio State University Antigenic modification of polypeptides
US4388995A (en) * 1981-06-08 1983-06-21 Ahn Min H Collapsible container
US4945050A (en) 1984-11-13 1990-07-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
CA1304886C (en) * 1986-07-10 1992-07-07 Heinz Dobeli Metal chelate resins
US5229490A (en) * 1987-05-06 1993-07-20 The Rockefeller University Multiple antigen peptide system
FR2664386B1 (fr) * 1990-07-05 1992-10-23 Sanofi Sa Trousse pour le dosage specifique de l'angiotensine ii.
US5171662A (en) * 1990-09-13 1992-12-15 The Upjohn Company Method of detecting HIV protease activity
CA2122717C (en) * 1991-11-08 2003-07-15 David C. Anderson Hemoglobins as drug delivery agents

Also Published As

Publication number Publication date
CA2294996A1 (en) 1998-12-30
AU8120398A (en) 1999-01-04
JP4850321B2 (ja) 2012-01-11
JP2002507886A (ja) 2002-03-12
EP1001978B1 (de) 2005-03-30
NZ501832A (en) 2002-12-20
CA2294996C (en) 2009-12-15
DE69829567T2 (de) 2006-02-16
AR014884A1 (es) 2001-04-11
EP1001978A1 (de) 2000-05-24
EP1486505A1 (de) 2004-12-15
AU748903B2 (en) 2002-06-13
ES2241147T3 (es) 2005-10-16
DK1001978T3 (da) 2005-08-01
ATE292143T1 (de) 2005-04-15
US20090105150A1 (en) 2009-04-23
PT1001978E (pt) 2005-08-31
WO1998058952A1 (en) 1998-12-30

Similar Documents

Publication Publication Date Title
DK1005446T3 (da) N-aroylphenylalaninderivater
ATE235220T1 (de) Resorcinderivate
ID22781A (id) Turunan-turunan nikotinamida
DE69817186D1 (de) Diaminorhodamin-derivate
ATE250583T1 (de) Substituierte 3-cyanochinoline
PT994890E (pt) Derivados de benzimidazole
PT915088E (pt) Derivados de d-prolina
ATE255098T1 (de) Substituierte chromanderivate
PT1003719E (pt) Derivados microbicidas de n-sulfonil-glicinalquiniloxifenemetilamida
PT1027362E (pt) Derivados de cetolidos 2-halogeno-6-o-substituidos
DE69841086D1 (de) 5-Deoxy-Cytidin-Derivate
ATE255099T1 (de) Substituierte chromanderivate
DE59813487D1 (de) Substituierte 4-benzoyl-pyrazole
DE69829682D1 (de) Cis-disubstituierte aminocycloalkyl-pyrrolidin-derivate
DE69828780D1 (de) Amidinocamptpthecin-derivate
NO981495D0 (no) Phenoxymetylpiperidin-derivater
DK1001978T3 (da) Angiotensinderivater
DK0966437T3 (da) 5-Aroylnaphthalenderivater
DK0960100T3 (da) Substituerede 4-benzoyl-pyrazoler
DK1015447T3 (da) Piperidinylmethyloxazolidinonderivat
DE59807877D1 (de) Substituierte 4-benzoyl-pyrazole
FI974129A (fi) Apuväline
DE59810960D1 (de) Substituierte phenyluracile
SE9702610D0 (sv) Klamma
NO970759D0 (no) Hjelpemiddel

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KUDLEK & GRUNERT PATENTANWAELTE PARTNERSCHAFT, 803